Dextroamphetamine Sulfateextended-release
Pricing Report NDC 0115-1702-10

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Dextroamphetamine Sulfateextended-release Extended-release (NDC 0115-1702-10) is $1.10615 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Feb 17, 2021.

As a provided by Amneal Pharmaceuticals Of New York Llc, this medication is distributed in a 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$1.10615
Per EA

Pricing Unit
Per EA Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Feb 17, 2021
Billable Units
90 EA
Estimated Package Price
$99.55
Data Status
As of May 26, 2021
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
G - Generic
Package NDC
0115-1702-10
Description
90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE
Pricing Methodology Explanation
The NADAC was carried forward from the previous file.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Mar 2018, the NADAC wholesale price for (NDC ) has moved within a range of $0.86067 to $2.33854 per EA. Over this 2 years and 11 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.8607 - $2.3385
Market Volatility
171.71% Variance
Latest Trend
1.20%
Date Unit Price Unit Source Method Rate
Feb 17, 2021 $1.10615 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Feb 17, 2021 $1.10615 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
Sep 23, 2020 $1.09302 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Sep 23, 2020 $1.09302 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
Mar 18, 2020 $1.35411 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Mar 18, 2020 $1.35411 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
Feb 19, 2020 $0.86067 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jan 22, 2020 $0.96140 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Dec 18, 2019 $0.92846 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Aug 21, 2019 $1.62895 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Aug 21, 2019 $1.62895 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
Jun 19, 2019 $1.19229 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jun 19, 2019 $1.19229 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
May 22, 2019 $1.24458 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Apr 17, 2019 $1.46115 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Feb 20, 2019 $1.31982 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Feb 20, 2019 $1.31982 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
Dec 19, 2018 $1.51365 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Dec 19, 2018 $1.51365 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
Jul 18, 2018 $1.60480 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jul 18, 2018 $1.60480 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
Jun 20, 2018 $1.80126 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
May 23, 2018 $2.33854 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Mar 14, 2018 $1.77118 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: July 08, 2026